Acute myelogenous leukemia

What is acute myelogenous leukemia?

Acute myelogenous leukemia (AML) is a type of leukemia that starts suddenly. Learn about symptoms, diagnosis, treatment and risks in our guide to AML.

Risk factors for acute myelogenous leukemia (AML)

Risks for acute myelogenous leukemia (AML) include genetic syndromes, high doses of radiation and smoking. Learn about AML risk.

Symptoms of leukemia

Symptoms may vary depending on whether you have an acute or chronic type of leukemia. Learn about the symptoms of leukemia.

Diagnosis of leukemia

Tests to diagnose leukemia, such as blood tests and imaging tests, are done when symptoms or routine tests suggest a problem. Learn about diagnosing leukemia.

Staging acute myelogenous leukemia (AML)

Acute myelogenous leukemia (AML) is not staged but described as untreated, in remission, relapsed or refractory. Learn about these descriptions of AML.

Disease progression of acute myelogenous leukemia (AML)

Acute myelogenous leukemia (AML) progresses quickly and can develop wherever blood travels. Learn about where AML can develop.

Prognosis and survival for acute myelogenous leukemia

Prognostic factors for acute myelogenous leukemia (AML) include chromosome changes, gene mutations and your age. Learn about prognostic factors for AML.

Treatments for acute myelogenous leukemia

Treatment for AML is based on factors including your age, chromosome changes, subtype of AML and your overall health. Learn about treatments for AML.

Supportive care for leukemia

Supportive care helps people with physical, practical and emotional aspects of leukemia. Learn how to cope with long-term effects of leukemia.

Research in acute myelogenous leukemia (AML)

We are always learning more about cancer. Researchers and healthcare professionals use what they learn from research studies to develop better practices that will help find and treat acute myelogenous leukemia (AML). They are also looking for ways to improve the quality of life of people with AML.

Acute myelogenous leukemia statistics

Acute myelogenous leukemia (AML) is a leading cause of adult leukemia deaths in Canada. Learn about incidence and mortality statistics for this cancer.